Maurizio Zangari

15PUBLICATIONS
30CO-AUTHORS
Medical infection agents (incl. prions)Gene and molecular therapyPredictive and prognostic markersMedical mycologyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 09, 2025
Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma.

Fumou Sun, Yan Cheng, Catherine Ma

|Aug 28, 2024
Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies.

Othman Salim Akhtar, Aniko Szabo, Vineel Bhatlapenumarthi

|Mar 31, 2022
First- versus second-generation Bruton tyrosine kinase inhibitors in Waldenström's Macroglobulinemia: A systematic review and meta-analysis.

Hassan Abushukair, Sebawe Syaj, Obada Ababneh

|Dec 11, 2019
Daratumumab in high-risk relapsed/refractory multiple myeloma patients: adverse effect of chromosome 1q21 gain/amplification and GEP70 status on outcome.

Meera Mohan, Niels Weinhold, Carolina Schinke

|Nov 09, 2018
Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes.

Syed J Mehdi, Sarah K Johnson, Joshua Epstein

|Apr 07, 2017
Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease.

Meera Mohan, Amy Buros, Pankaj Mathur

Pageof 3

Frequent Collaborators

8 joint publications

Carolina Schinke

6 joint publications

Sharmilan Thanendrarajan

6 joint publications

Frits van Rhee

6 joint publications

Samer Al-Hadidi